BINDING AND ACTIVATION OF PLASMINOGEN AT THE SURFACE OF HUMAN KERATINOCYTES

被引:52
作者
REINARTZ, J
BATRLA, R
BOUKAMP, P
FUSENIG, N
KRAMER, MD
机构
[1] UNIV HEIDELBERG,INST IMMUNOL & SEROL,IMMUNOPATHOL LAB,NEUENHEIMER FELD 305,W-6900 HEIDELBERG,GERMANY
[2] GERMAN CANC RES CTR,DIV CARCINOGENESIS & DIFFERENTIAT,W-6900 HEIDELBERG,GERMANY
关键词
D O I
10.1006/excr.1993.1238
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Plasmin is thought to be involved in the pericellular proteolysis of the human epidermis under physiological and pathological conditions. Plasmin is provided by activation of the proenzyme plasminogen. We have explored in vitro whether plasminogen is bound and activated at the keratinocyte surface, a possible mechanism for providing plasm in in the pericellular space. Plasminogen and plasmin could be eluted from the surface of keratinocytes grown in serum-containing medium. When plasminogen was added to cultured keratinocytes it was activated by cell-associated urokinase-type plasminogen activator. The activation required plasminogen binding to the cell surface. Plasminogen binding by keratinocytes was saturable and proceeded in a time-and concentration-dependent manner. Surface-bound plasmin was rapidly displaced from the surface into the culture supernatant. When compared to plasmin in solution surface-bound plasmin was relatively protected from interaction with the specific inhibitor α2-antiplasmin. Addition of exogenous plasmin or plasmin generation by the keratinocyte-associated plasminogen activators was ensued by the detachment of adherent keratinocytes in culture. Along the same line, plasmin counteracted keratinocyte adhesion to fibrin-coated but not to collagen-coated culture plates. The findings indicate that plasmin may be generated in the pericellular space of keratinocytes and may interfere with the adhesion to particular extracellular substrates. © 1993 Academic Press, Inc.
引用
收藏
页码:197 / 208
页数:12
相关论文
共 46 条
[1]   MESSENGER-RNA FOR TISSUE-TYPE PLASMINOGEN-ACTIVATOR IS PRESENT IN LESIONAL EPIDERMIS FROM PATIENTS WITH PSORIASIS, PEMPHIGUS, OR BULLOUS PEMPHIGOID, BUT IS NOT DETECTED IN NORMAL EPIDERMIS [J].
BAIRD, J ;
LAZARUS, GS ;
BELIN, D ;
VASSALLI, JD ;
BUSSO, N ;
GUBLER, P ;
JENSEN, PJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 95 (05) :548-552
[2]  
BEHRENDT N, 1990, J BIOL CHEM, V265, P6453
[3]   PLASMINOGEN ACTIVATION BY T-PA ON THE SURFACE OF HUMAN-MELANOMA CELLS IN THE PRESENCE OF ALPHA-2-MACROGLOBULIN SECRETION [J].
BIZIK, J ;
LIZONOVA, A ;
STEPHENS, RW ;
GROFOVA, M ;
VAHERI, A .
CELL REGULATION, 1990, 1 (12) :895-905
[4]   UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - PROENZYME, RECEPTOR, AND INHIBITORS [J].
BLASI, F ;
VASSALLI, JD ;
DANO, K .
JOURNAL OF CELL BIOLOGY, 1987, 104 (04) :801-804
[5]   NORMAL KERATINIZATION IN A SPONTANEOUSLY IMMORTALIZED ANEUPLOID HUMAN KERATINOCYTE CELL-LINE [J].
BOUKAMP, P ;
PETRUSSEVSKA, RT ;
BREITKREUTZ, D ;
HORNUNG, J ;
MARKHAM, A ;
FUSENIG, NE .
JOURNAL OF CELL BIOLOGY, 1988, 106 (03) :761-771
[6]  
BREITKREUTZ D, 1991, CANCER RES, V51, P4402
[7]   PLASMINOGEN BINDING-SITES IN NORMAL HUMAN SKIN [J].
BURGE, SM ;
MARSHALL, JM ;
CEDERHOLMWILLIAMS, SA .
BRITISH JOURNAL OF DERMATOLOGY, 1992, 126 (01) :35-41
[8]   LIMITED PROTEOLYSIS OF TUMOR-CELLS INCREASES THEIR PLASMIN-BINDING ABILITY [J].
CAMACHO, M ;
FONDANECHE, MC ;
BURTIN, P .
FEBS LETTERS, 1989, 245 (1-2) :21-24
[9]  
COLLEN D, 1980, THROMB HAEMOSTASIS, V43, P77
[10]   PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER [J].
DANO, K ;
ANDREASEN, PA ;
GRONDAHLHANSEN, J ;
KRISTENSEN, P ;
NIELSEN, LS ;
SKRIVER, L .
ADVANCES IN CANCER RESEARCH, 1985, 44 :139-266